In this article, we will be taking a look at the 5 biggest biotechnology companies in the world.
Keep Reading →
March 17 - News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
Aristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity Strategy” fourth quarter 2023 investor letter.
Keep Reading →
March 4 - Hedge Fund Investor Letters, News
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Keep Reading →
February 17 - Hedge Funds, News
In this article, we discuss the top 5 CRISPR stocks to invest in.
Keep Reading →
February 10 - News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
Harding Loevner, an asset management company, released its “Global Equity Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
February 9 - Hedge Fund Investor Letters, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode.
Keep Reading →
February 6 - News, Transcripts
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
Keep Reading →
January 22 - Hedge Funds, News
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
Keep Reading →
December 20 - Hedge Funds, News
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - Industries, Lists, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Keep Reading →
November 16 - Hedge Funds, News
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this piece, we will take a look at the 12 best low beta stocks to buy.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
Operator: Good day and welcome to the Vertex Pharmaceuticals Third Quarter 2023 Conference Call. All participants will be in a listen only mode.
Keep Reading →
November 7 - News, Transcripts
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
In this article, we shall cover the top 30 oncology companies in the world.
Keep Reading →
October 13 - Business, Hedge Funds, Lists, News
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” second quarter 2023 investor letter.
Keep Reading →
September 20 - Hedge Fund Investor Letters, News
Operator: Good afternoon and welcome to the Vertex Pharmaceuticals Second Quarter 2023 Earnings Conference Call.
Keep Reading →
August 2 - News, Transcripts
In this article, we discuss 5 DNA stocks that billionaires love.
Keep Reading →
June 14 - Hedge Funds, News
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
May 18 - Hedge Fund Investor Letters, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals First Quarter 2023 Conference Call. All participants will be in a listen-only mode.
Keep Reading →
May 4 - News, Transcripts
In this article, we take a look at 27 largest biotech companies in the US.
Keep Reading →
April 29 - Lists, News
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Keep Reading →
April 26 - Hedge Funds, News
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
Keep Reading →
April 20 - Hedge Funds, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter and Full Year 2022 Conference Call. All participants will be in a listen-only mode.
Keep Reading →
February 9 - News, Transcripts
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Keep Reading →
January 21 - Hedge Funds, News
Below we take a look at Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks.
Keep Reading →
December 31 - Hedge Funds, News
In this article, we discuss the 5 biotech stocks with the biggest upside.
Keep Reading →
December 13 - Hedge Funds, News
Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
November 16 - Hedge Fund Investor Letters, News
ClearBridge Investments, an investment management company, released its “ClearBridge Aggressive Growth Strategy” third quarter 2022 investor letter.
Keep Reading →
November 8 - Hedge Fund Investor Letters, News
All three key U.S. indices jumped this morning, thanks to better-than-expected earnings of giants like Apple Inc.
Keep Reading →
October 28 - News
Cardinal Health, Inc. (NYSE:CAH) offers investors a forward dividend yield of 2.91% as of October 21.
Keep Reading →
October 24 - Hedge Funds, News
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California.
Keep Reading →
October 14 - Hedge Funds, News
Carillon Tower Advisers, an investment management company, released its “Carillon Scout Mid Cap Fund” second quarter 2022 investor letter.
Keep Reading →
October 7 - Hedge Fund Investor Letters, News
In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.
Keep Reading →
October 7 - Hedge Funds, News
In this article, we discuss the 5 stocks Australian billionaire Kerr Neilson is selling.
Keep Reading →
September 23 - Hedge Funds, News
In this article, we discuss the top 10 stock picks of Roberto Mignone's Bridger Management.
Keep Reading →
September 15 - Hedge Funds, News
In this article, we discuss the top 10 stock picks of Henrik Rhenman's Rhenman Partners.
Keep Reading →
September 14 - Hedge Funds, News
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
Keep Reading →
September 5 - Lists, News
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here.
Keep Reading →
August 16 - Hedge Fund Investor Letters, News
In this article, we discuss the 5 healthcare stocks making moves after earnings.
Keep Reading →
August 8 - News
In this piece, we will take a look at the twelve best healthcare stocks to buy now.
Keep Reading →
August 4 - Hedge Funds, News
In this article, we shall be going through the top 10 stock picks of Efrem Kamen's Pura Vida Investments.
Keep Reading →
July 28 - Hedge Funds, News
Below we take a look at Disney (DIS) and 4 Other Stocks Billionaire Phill Gross Was Buying Up in Q1.
Keep Reading →
July 7 - Hedge Funds, News
In this article, we discuss the 10 Cathie Wood stocks hedge funds are selling.
Keep Reading →
June 3 - Hedge Funds, News
In this article, we discuss the 5 earnings reports catching investors' attention.
Keep Reading →
May 6 - News